Treating Acute MI Patients With Aggrastat on Their Way to Hospital

This study is currently recruiting participants.

Verified by The Baruch Padeh Medical Center, Poriya, January 2009

First Received: March 1, 2006 Last Updated: January 18, 2009 History of Changes

Sponsored by:	The Baruch Padeh Medical Center, Poriya
Information provided by:	The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:	NCT00300833

Purpose

Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

Condition	Intervention	Phase
Acute Myocardial Infarction	Drug: Tirofiban	Phase IV

MedlinePlus related topics: Heart Attack

Drug Information available for: Tirofiban hydrochloride Tirofiban Tirofiban hydrochloride monohydrate

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Efficacy Study

Further study details as provided by The Baruch Padeh Medical Center, Poriya:

Primary Outcome Measures:

mortality

Secondary Outcome Measures:

TIMI flow

Estimated Enrollment:	200
Study Start Date:	January 2006

Intervention Details:

pci

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital

Exclusion Criteria:

women less than 50 years old and 80 years old, bleeding tendency, stroke in the past

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00300833

Contacts

Contact: Yonathan Hasin, Professor

97246652648

yhasin@poria.health.gov.il

Locations

Israel
Cardiovascular Division, The Baruch Padeh Medical Center, Poriya,	Recruiting
Tiberias, Israel, 15208
Magen David ,	Recruiting
Tiberias, Israel
Contact: Sergay Krablikov, Dr

Sponsors and Collaborators

The Baruch Padeh Medical Center, Poriya

Investigators

Study Chair:

Menachem Naheer

The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel

More Information

No publications provided

Responsible Party:	The baruch Padeh Medical center ( Menachem Nahir )
Study ID Numbers:	Aggrastat in AMI.CTIL
Study First Received:	March 1, 2006
Last Updated:	January 18, 2009
ClinicalTrials.gov Identifier:	NCT00300833 History of Changes
Health Authority:	Israel: Israeli Health Ministry Pharmaceutical Administration

Study placed in the following topic categories:

Necrosis
Heart Diseases
Tirofiban
Myocardial Ischemia

Vascular Diseases
Ischemia
Infarction
Myocardial Infarction

Additional relevant MeSH terms:

Necrosis
Heart Diseases
Pathologic Processes
Myocardial Ischemia
Vascular Diseases

Cardiovascular Diseases
Ischemia
Infarction
Myocardial Infarction

ClinicalTrials.gov processed this record on May 07, 2009